Sinn Féin - On Your Side

GlaxoSmithKline Irish indemnity deal should be probed – Ó Caoláin

3 July, 2012 - by Caoimhghín Ó Caoláin TD


Following the news that the giant pharmaceutical multinational corporation GlaxoSmithKline has been fined $3 billion for massive malpractice and fraud in the United States, Sinn Féin Health & Children spokesperson Caoimhghín Ó Caoláin TD has reiterated his call for an investigation into the indemnity deal between the last Government and this multinational manufacturer of a flu vaccine which has caused a sleeping disorder in some 30 children in Ireland.
Deputy Ó Caoláin said:
“GlaxoSmithKline has been guilty of massive malpractice in the United States, incurring fines totalling $3 billion. This included marketing drugs for unauthorised uses and holding back safety data. There needs to be an immediate investigation into the granting by the last government of an absolute indemnity to GlaxoSmithKline, the manufacturers of Pandemrix which caused the sleeping disorder narcolepsy in Irish children.
“When the Joint Committee on Health and Children met on 8 September 2009 to address the swine flu issue, I and other members, including James Reilly TD, then in Opposition, expressed concern about the indemnity granted to GlaxoSmithKline. When I asked Minister Reilly in September 2011 if the nature of that indemnity was such that GlaxoSmithKline will be legally absolved from any accountability for the drug causing narcolepsy in Irish children, he did not reply.
“We need an investigation of this and full answers from the Minister all the more urgently now.” ENDS

Connect with Sinn Féin